However, the expression level of HSP60 was not significantly related to the following clinicopathological parameters: age, sex, diabetes mellitus, family history, smoking, anemia, WBCs count, serum CEA level, tumor location, TNM classification, or EGFR mutation. This evidence concerns the gene CEACAM5 and diabetes mellitus.